Home/Filings/4/0001127602-15-004380
4//SEC Filing

ALLERGAN INC 4

Accession 0001127602-15-004380

CIK 0000850693operating

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 6:21 PM ET

Size

7.2 KB

Accession

0001127602-15-004380

Insider Transaction Report

Form 4
Period: 2015-02-02
Transactions
  • Award

    Phantom Stock Units

    2015-02-02$220.79/sh+10.88$2,4027,513.21 total
    Common Stock (10.88 underlying)
  • Award

    Phantom Stock Units

    2015-02-03$220.36/sh+9.08$2,0017,522.29 total
    Common Stock (9.08 underlying)
Footnotes (3)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program.
  • [F3]Phantom stock units are to be settled 100% in common stock upon the Reporting Person's retirement as an Allergan, Inc. director.

Issuer

ALLERGAN INC

CIK 0000850693

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000850693

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:21 PM ET
Size
7.2 KB